Orient Pharma Co., Ltd. (4166)
Market Closed
12 Aug, 05:30
TWSE 
JPX Primary TWSE NT$
24. 40
-0.1
-0.4082%
NT$
- Market Cap
- P/E Ratio
- Div Yield
78,542 Volume
- Eps
NT$ 24.5
Previous Close Want to track 4166 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Orient Pharma Co., Ltd. (4166) Statistics
Valuation metrics
Market Cap -
Enterprise value 5.6B
Trailing P/E (ttm) 30.06
Forward P/E -
PEG ratio 0.46
Price/Sales (ttm) 4.29
Price/Book (mrq) 2.33
Enterprise Value/Revenue 3.96
Enterprise Value/EBITDA 16.67
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 209.51K
Average volume (90 days) 377.59K
Price summary
52-Week low 22.3
52-Week high 32.45
Beta -
50-Day moving average 25.69
200-Day moving average 25.56
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 541:500
Last split Date 8 Jul 2020
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.14%
Operating margin 0.18%
Operational effectiveness
Return on assets 0.07%
Return on equity 0.08%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 5.82
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.81
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.74
Total debt (mrq) -
Total Debt/Equity (mrq) 0.07
Current ratio (mrq) 8.15%
Book value per share (mrq) 10.71
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
